432 related articles for article (PubMed ID: 22290500)
21. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the transcriptional control region of JC polyomavirus in cerebrospinal fluid from HIV-negative patients with progressive multifocal leucoencephalopathy.
Fedele CG; Polo C; Tenorio A; Niubò J; Ciardi MR; Pérez JL
J Med Virol; 2006 Oct; 78(10):1271-5. PubMed ID: 16927288
[TBL] [Abstract][Full Text] [Related]
23. HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.
Iannetta M; Bellizzi A; Lo Menzo S; Anzivino E; D'Abramo A; Oliva A; D'Agostino C; d'Ettorre G; Pietropaolo V; Vullo V; Ciardi MR
J Neurovirol; 2013 Jun; 19(3):274-9. PubMed ID: 23715894
[TBL] [Abstract][Full Text] [Related]
24. Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS.
Richardson-Burns SM; Kleinschmidt-DeMasters BK; DeBiasi RL; Tyler KL
Arch Neurol; 2002 Dec; 59(12):1930-6. PubMed ID: 12470182
[TBL] [Abstract][Full Text] [Related]
25. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
Koralnik IJ; Du Pasquier RA; Letvin NL
J Virol; 2001 Apr; 75(7):3483-7. PubMed ID: 11238876
[TBL] [Abstract][Full Text] [Related]
26. [New trends in progressive multifocal leukoencephalopathy].
Gasnault J; Taoufik Y
Rev Neurol (Paris); 2006 Jan; 162(1):43-56. PubMed ID: 16446622
[TBL] [Abstract][Full Text] [Related]
27. Reactivation of human polyomavirus JC in patients affected by psoriasis vulgaris and psoriatic arthritis and treated with biological drugs: preliminary results.
Nardis C; Anzivino E; Bellizzi A; Rodio DM; De Pità O; Chiarini F; Pietropaolo V
J Cell Physiol; 2012 Dec; 227(12):3796-802. PubMed ID: 22422468
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies and progressive multifocal leukoencephalopathy.
Berger JR; Houff SA; Major EO
MAbs; 2009; 1(6):583-9. PubMed ID: 20073129
[TBL] [Abstract][Full Text] [Related]
29. Immunosuppression increases JC polyomavirus large T antigen DNA load in the brains of patients without progressive multifocal leukoencephalopathy.
Bayliss J; Karasoulos T; McLean CA
J Infect Dis; 2013 Jan; 207(1):133-6. PubMed ID: 23112281
[TBL] [Abstract][Full Text] [Related]
30. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases.
Boren EJ; Cheema GS; Naguwa SM; Ansari AA; Gershwin ME
J Autoimmun; 2008; 30(1-2):90-8. PubMed ID: 18191544
[TBL] [Abstract][Full Text] [Related]
31. The Role of the JC Virus in Central Nervous System Tumorigenesis.
Ahye N; Bellizzi A; May D; Wollebo HS
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872288
[TBL] [Abstract][Full Text] [Related]
32. Bridging the Gap: Immunotherapy in Progressive Multifocal Leukoencephalopathy: A New Hope?
Born T; Vassallo P; Golshayan D; Di Liberto G; Brouland JP; Egervari K; Merkler D; Du Pasquier RA; Bernard-Valnet R
Neurology; 2023 Sep; 101(13):e1382-e1386. PubMed ID: 37407265
[TBL] [Abstract][Full Text] [Related]
33. Reactivation of JC virus and development of PML in patients with multiple sclerosis.
Khalili K; White MK; Lublin F; Ferrante P; Berger JR
Neurology; 2007 Mar; 68(13):985-90. PubMed ID: 17389301
[TBL] [Abstract][Full Text] [Related]
34. Molecular biology and immunoregulation of human neurotropic JC virus in CNS.
Sweet TM; Del Valle L; Khalili K
J Cell Physiol; 2002 Jun; 191(3):249-56. PubMed ID: 12012320
[TBL] [Abstract][Full Text] [Related]
35. John Cunningham virus: an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy.
Pietropaolo V; Prezioso C; Bagnato F; Antonelli G
New Microbiol; 2018 Jul; 41(3):179-186. PubMed ID: 29620790
[TBL] [Abstract][Full Text] [Related]
36. Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors.
Tan CS; Ghofrani J; Geiger E; Koralnik IJ; Jost S
J Acquir Immune Defic Syndr; 2019 Oct; 82(2):220-224. PubMed ID: 31513076
[TBL] [Abstract][Full Text] [Related]
37. Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy.
Wüthrich C; Koralnik IJ
J Neuropathol Exp Neurol; 2012 Jan; 71(1):54-65. PubMed ID: 22157619
[TBL] [Abstract][Full Text] [Related]
38. Progressive multifocal leukoencephalopathy.
Weissert R
J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
[TBL] [Abstract][Full Text] [Related]
39. Immunosuppression increases latent infection of brain by JC polyomavirus.
Bayliss J; Karasoulos T; Bowden S; Glogowski I; McLean CA
Pathology; 2011 Jun; 43(4):362-7. PubMed ID: 21532525
[TBL] [Abstract][Full Text] [Related]
40. Propagation of archetype and nonarchetype JC virus variants in human fetal brain cultures: demonstration of interference activity by archetype JC virus.
O'Neill FJ; Greenlee JE; Dörries K; Clawson SA; Carney H
J Neurovirol; 2003 Oct; 9(5):567-76. PubMed ID: 13129771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
